{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:43:58Z","timestamp":1775079838487,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.eplepsyres.2026.107756","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:03:43Z","timestamp":1771358623000},"page":"107756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study"],"prefix":"10.1016","volume":"222","author":[{"given":"Qiuxiao","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kefu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2026.107756_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.seizure.2025.05.003","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism: a systematic review and meta-analysis","volume":"130","author":"Amaral de Lara","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/acps.13797","article-title":"Gestational Exposure to Valproate and Autism Spectrum Disorder or Attention-Deficit\/Hyperactivity Disorder in Offspring: Systematic Review and Meta-Analysis","author":"Andrade","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cells14120915","article-title":"Exome study of single nucleotide variations in patients with syndromic and non-syndromic autism reveals potential candidate genes for diagnostics and novel single nucleotide variants","volume":"14","author":"Belenska-Todorova","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.seizure.2025.05.024","article-title":"Autism and prenatal exposure to antiseizure medications: still a long-standing blind spot?","volume":"131","author":"Braillon","year":"2025","journal-title":"Seizure. Eur. J. Epilepsy"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2017.05.017","article-title":"Altered gene expression in early postnatal monoamine oxidase A knockout mice","volume":"1669","author":"Chen","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105314","article-title":"A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database","volume":"107","author":"Chen","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib9","series-title":"Current challenges in pharmacovigilance: pragmatic approaches","author":"CIOMS working group V","year":"2001"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147399","article-title":"Association of GABRG3, GABRB3, HTR2A gene variants with autism spectrum disorder","volume":"870","author":"Coskunpinar","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74409-x","article-title":"Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France","volume":"10","author":"Coste","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib12","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib13","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/cid\/ciz684","article-title":"Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy","volume":"70","author":"van De Ven","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52155","article-title":"The single-cell eQTLGen consortium","volume":"9","author":"van der Wijst","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0962280206077743","article-title":"Mendelian randomization as an instrumental variable approach to causal inference","volume":"16","author":"Didelez","year":"2007","journal-title":"Stat. Methods Med Res"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal exposure to antiseizure medication and incidence of childhood- and adolescence-onset psychiatric disorders","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib18","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1093\/brain\/awac296","article-title":"Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability","volume":"145","author":"Feleke","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.neubiorev.2012.02.010","article-title":"A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4","volume":"36","author":"Greenwood","year":"2012","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"GTEx Consortium","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib21","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2309359","article-title":"Risk of autism after prenatal topiramate, valproate, or lamotrigine exposure","volume":"390","author":"Hern\u00e1ndez-D\u00edaz","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib23","article-title":"Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Antiseizure Medication: A Systematic Review","volume":"102","author":"Honybun","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112952","article-title":"Mendelian randomization in pharmacogenomics: the unforeseen potentials","volume":"150","author":"Khasawneh","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib26","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib28","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41588-025-02224-z","article-title":"Decomposition of phenotypic heterogeneity in autism reveals underlying genetic programs","volume":"57","author":"Litman","year":"2025","journal-title":"Nat. Genet"},{"key":"10.1016\/j.eplepsyres.2026.107756_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110658","article-title":"Women with epilepsy during pregnancy: a systematic review of current guidelines","volume":"171","author":"Liu","year":"2025","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221101687","article-title":"Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide","volume":"15","author":"Nucera","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40264-018-0647-1","article-title":"EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection","volume":"41","author":"Postigo","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib32","article-title":"Teratogenesis, perinatal, and neurodevelopmental outcomes after In utero exposure to antiseizure medication","author":"Practice Guideline From the AAN, AES, and SMFM","year":"2025","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/toxsci\/kfv094","article-title":"Gene expression regulation and pathway analysis after valproic acid and carbamazepine exposure in a human embryonic stem cell-based neurodevelopmental toxicity assay","volume":"146","author":"Schulpen","year":"2015","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib34","unstructured":"Systems medicine, 2020."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1440145","article-title":"Exposure to anti-seizure medication during pregnancy and the risk of autism and ADHD in offspring: a systematic review and meta-analysis","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaip.2020.09.021","article-title":"Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)","volume":"9","author":"Yu","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pr."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00415-025-13172-3","article-title":"Safety concerns of maternal antiseizure medications exposure on perinatal and offspring outcomes: a disproportionality analysis based on FDA adverse event reporting system","volume":"272","author":"Zeng","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2026.107756_bib38","article-title":"Frailty and cardiometabolic diseases: a bidirectional Mendelian randomisation study","volume":"51","author":"Zhu","year":"2022","journal-title":"Age Ageing"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121126000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:41:22Z","timestamp":1775072482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121126000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"alternative-id":["S0920121126000264"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107756","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal exposure to antiseizure medications and risk of autism spectrum disorder in offspring: an integrated pharmacovigilance and two-sample mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2026.107756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107756"}}